Gastrointestinal stromal tumors in Iceland, 1990-2003: The Icelandic GIST study, a population-based incidence and pathologic risk stratification study

作者: Geir Tryggvason , Hjörtur G Gíslason , Magnús K Magnússon , Jón G Jónasson , None

DOI: 10.1002/IJC.21167

关键词:

摘要: Gastrointestinal stromal tumor (GIST) is a newly defined clinical and pathologic entity. This study examines the whole population-based incidence of GIST as well risk stratification schemes. All patients diagnosed in Iceland with gastrointestinal mesenchymal over years 1990-2003 were evaluated an immunohistochemical panel including staining for c-kit. The age-adjusted was calculated. Size, mitotic rate per 50 HPF various other parameters evaluated. Each categorized into 1 4 recently NIH categories. Fifty-seven tumors positive c-kit therefore GIST. annual period 1.1 100,000. median age 65.8 size 4.6 cm. Only 2 35 gastric fall high-risk category while half nongastric (11 22) this category. Eight 57 (14%) metastasized, 7 which nongastric. predictive value malignant behavior 46%. negative low- very-low-risk 100%. Pathologic predictors are size, rate, mucosal disruption, necrosis high cellularity. Nongastric GISTs clearly at much higher than GISTs. estimates 100,000 furthermore supports consensus categories prediction

参考文章(25)
Helen E. Remotti, Frank Aldenborg, Jeanne M. Meis-Kindblom, Lars Gunnar Kindblom, Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. American Journal of Pathology. ,vol. 152, pp. 1259- 1269 ,(1998)
Lisa Sarran, Peter Besmer, Ronald P DeMatteo, Sylvia J Tschernyavsky, Marc Ladanyi, Robert Maki, Mark Robson, Elyn Riedel, James M Woodruff, Murray F Brennan, Cristina R Antonescu, Gunhild Sommer, Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clinical Cancer Research. ,vol. 9, pp. 3329- 3337 ,(2003)
Thorunn Rafnar, Steinunn Thorlacius, Eirikur Steingrimsson, Mikkel H. Schierup, Jesper N. Madsen, Violeta Calian, Bjarki J. Eldon, Thorvaldur Jonsson, Jotun Hein, Snorri S. Thorgeirsson, The Icelandic Cancer Project--a population-wide approach to studying cancer. Nature Reviews Cancer. ,vol. 4, pp. 488- 492 ,(2004) , 10.1038/NRC1371
Maria Debiec-Rychter, Bartosz Wasag, Michel Stul, Ivo De Wever, Allan Van Oosterom, Anne Hagemeijer, Raf Sciot, Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity The Journal of Pathology. ,vol. 202, pp. 430- 438 ,(2004) , 10.1002/PATH.1546
J.-P. E. N. Pierie, The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal Tumors Archives of Surgery. ,vol. 136, pp. 383- 389 ,(2001) , 10.1001/ARCHSURG.136.4.383
Markku Miettinen, Maarit Sarlomo-Rikala, Leslie H. Sobin, Jerzy Lasota, Gastrointestinal Stromal Tumors and Leiomyosarcomas in the Colon The American Journal of Surgical Pathology. ,vol. 24, pp. 1339- 1352 ,(2000) , 10.1097/00000478-200010000-00003
Theresa S. Emory, Leslie H. Sobin, Laura Lukes, Dong H. Lee, Timothy J. O'Leary, Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. The American Journal of Surgical Pathology. ,vol. 23, pp. 82- 87 ,(1999) , 10.1097/00000478-199901000-00009
Christopher D.M. Fletcher, Jules J. Berman, Christopher Corless, Fred Gorstein, Jerzy Lasota, B.Jack Longley, Markku Miettinen, Timothy J. O'Leary, Helen Remotti, Brian P. Rubin, Barry Shmookler, Leslie H. Sobin, Sharon W. Weiss, Diagnosis of gastrointestinal stromal tumors: A consensus approach Human Pathology. ,vol. 33, pp. 459- 465 ,(2002) , 10.1053/HUPA.2002.123545
Christopher D.M. Fletcher, Heikki Joensuu, George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter J. Roberts, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra L. Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Sasa Dimitrijevic, Brian J. Druker, Christopher Corless, Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine. ,vol. 347, pp. 472- 480 ,(2002) , 10.1056/NEJMOA020461
Markku Miettinen, Mary Furlong, Maarit Sarlomo-Rikala, Allen Burke, Leslie H. Sobin, Jerzy Lasota, Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases The American Journal of Surgical Pathology. ,vol. 25, pp. 1121- 1133 ,(2001) , 10.1097/00000478-200109000-00002